Minimal change disease historical perspective
Minimal Change Disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Minimal change disease historical perspective On the Web |
American Roentgen Ray Society Images of Minimal change disease historical perspective |
Risk calculators and risk factors for Minimal change disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Minimal change disease was first described by F. Munk in 1913, when he coined the term “lipoid nephrosis” following the observation of lipid-laden macrophages in the proximal tubular epithelial cells and oval fat bodies in urine. In 1925, Fahr and colleagues noted the resemblance of minimal change disease to focal segmental glomerulosclerosis (FSGS). Ever since its early description, the term “lipoid nephrosis” has been criticized due to the clinical irrelevance of the lipid-laden cells seen on microscopy.
Historical Perspective
Discovery
- The term “lipoid nephrosis,” introduced in the early 1900s in which microscopic lipid droplets in urine and tubular cells were noticed in minimal change disease.[1][2]
- Minimal change disease was discovered, in 1950s during ultra-structural analyses and extensive fusion of podocyte foot processes was observed.[3][4]
References
- ↑ Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). "Minimal Change Disease". Clinical Journal of the American Society of Nephrology. 12 (2): 332–345. doi:10.2215/CJN.05000516. ISSN 1555-9041.
- ↑ D'Agati V (2003). "Pathologic classification of focal segmental glomerulosclerosis". Semin Nephrol. 23 (2): 117–34. doi:10.1053/snep.2003.50012. PMID 12704572.
- ↑ Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). "Minimal Change Disease". Clinical Journal of the American Society of Nephrology. 12 (2): 332–345. doi:10.2215/CJN.05000516. ISSN 1555-9041.
- ↑ FARQUHAR MG, VERNIER RL, GOOD RA (November 1957). "An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus". J. Exp. Med. 106 (5): 649–60. PMC 2136823. PMID 13475621.